Pregnancy outcome and management of 25 pregnancies in women with polycythemia vera

Am J Hematol. 2018 Sep;93(9):E234-E235. doi: 10.1002/ajh.25210. Epub 2018 Aug 31.

Authors

Irene Bertozzi¹, Elisa Rumi^{2

3}, Chiara Cavalloni³, Mario Cazzola^{2

3}, Fabrizio Fabris¹, Maria L Randi¹

Affiliations

¹ First Medical Clinic, Department of Medicine-DIMED, University of Padova, Padova, Italy.
² Department of Molecular Medicine, University of Pavia, Pavia, Italy.
³ Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.

PMID: 29989197
DOI: 10.1002/ajh.25210

No abstract available

Publication types

Letter

MeSH terms

Abortion, Spontaneous / etiology*
Adolescent
Adult
Child
Female
Fibrinolytic Agents / therapeutic use
Humans
Italy
Janus Kinase 2 / genetics
Mutation
Polycythemia Vera / drug therapy*
Pregnancy
Pregnancy Complications, Hematologic / drug therapy*
Pregnancy Outcome*
Retrospective Studies
Young Adult

Substances

Fibrinolytic Agents
JAK2 protein, human
Janus Kinase 2